HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 2,737-2,748 of 4,505
Behavioral study icon
CompletedNCT03714698

Effects of Pilates Exercise Program in people with Schizophrenia

Official study title

Effects of Pilates-based Exercises on Functional Capacity and Mental Health in Patients With Schizophrenia

This study has finished and is no longer accepting participants.

In Zonguldak
SchizophreniaPlacebo comparisonAges 35–40
Countries
Türkiye
Sponsor
Hacettepe University
Device study icon
CompletedNCT01523730

Effects of rTMS on Cigarette Smoking and Cognition in Schizophrenia

Official study title

Effects of Repetitive Transcranial Magnetic Stimulation on Cigarette Smoking and Cognitive Function in Smokers With and Without Schizophrenia

This study has finished and is no longer accepting participants.

In Toronto
Schizophrenia, AddictionDevice studyAges 18–55
Countries
Canada
Sponsor
Centre for Addiction and Mental Health (Hospital / academic medical center)
Drug study icon
CompletedNCT01934023

Effects of Varenicline on Plasticity in Schizophrenia

Official study title

Effects of Varenicline on Cortical Neuroplasticity and Working Memory in Patients With Schizophrenia and Healthy Controls

This study has finished and is no longer accepting participants.

In Toronto
SchizophreniaMedication studyAges 18–55
Countries
Canada
Sponsor
Centre for Addiction and Mental Health (Hospital / academic medical center)
Drug study icon
CompletedNCT01850953

Effects of Varenicline on Smoking Lapse in Smokers With and Without Schizophrenia

Official study title

Evaluating the Effects of Varenicline on Smoking Lapse in Smokers With and Without Schizophrenia: Implications for Treatment

This study has finished and is no longer accepting participants.

In Toronto
SchizophreniaMedication studyAges 18–55
Countries
Canada
Sponsor
Centre for Addiction and Mental Health (Hospital / academic medical center)
Drug study icon
WithdrawnNCT00988728

Efficacy & Safety of SCH 900435 in Schizophrenia (Study P06079)(WITHDRAWN)

Official study title

A Multicenter, Randomized, Parallel-Group, Double-blind, Fixed-Dose, 28-Day Trial to Assess the Efficacy and Safety of SCH 900435 Compared With Placebo, Using Olanzapine as an Active Control in Subjects With an Acute Exacerbation of Schizophrenia (GUEST - Glycine Uptake Inhibitor Efficacy and Safety Trial, Phase 2, Protocol No. P06079)

This study was withdrawn before enrollment.

Location not clearly listed
SchizophreniaMedication studyAges 18+
Countries
Sponsor
Merck Sharp & Dohme LLC
Drug study icon
CompletedNCT02970292

Pimavanserin for schizophrenia

What is this study about?

This study evaluated the safety and effectiveness of Pimavanserin for people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Phoenix
SchizophreniaMedication studyAges 18–55
Countries
United States, Canada, Bulgaria, + 7 others
Sponsor
ACADIA Pharmaceuticals Inc.
Drug study icon
TerminatedNCT00439634

AVE1625 for schizophrenia

What is this study about?

Researchers are comparing AVE1625 and placebo to find out how the approaches affect memory, attention and other thinking skills in people with schizophrenia.

This study ended early.

Multiple locations, including Bridgewater
SchizophreniaMedication studyAges 18–65
Countries
United States, Canada
Sponsor
Sanofi
Drug study icon
CompletedNCT02970305

Pimavanserin for schizophrenia

What is this study about?

This study evaluated the safety and effectiveness of Pimavanserin for people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Phoenix
SchizophreniaMedication studyAges 18–55
Countries
United States, Canada, Bulgaria, + 7 others
Sponsor
ACADIA Pharmaceuticals Inc.
Drug study icon
CompletedNCT00859872

Risperidone with clonazepam or haloperidol for psychotic agitation

About this title

Efficacy and Safety of Risperidone Oral Solution Combination Clonazepam Versus Haloperidol Intramuscular (IM) Injection for Treatment of Acute Psychotic Agitation in Schizophrenia

Read the official source — NCT00859872
What is this study about?

This study evaluated the safety and effectiveness of risperidone oral solution for people with schizophrenia.

This study has finished and is no longer accepting participants.

In Changsha
SchizophreniaMedication studyAges 18–45
Countries
China
Sponsor
Central South University

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.